kw.\*:("CELLULE P3HR1")
Results 1 to 17 of 17
Selection :
HETEROGENEITY OF EPSTEIN-BARR VIRUS ORIGINATING FROM P3HR-1 CELLS. I. STUDIES ON EBNA INDUCTION.FRESEN KO; MERKT B; BORNKAMM GW et al.1977; INTERNATION J. CANCER; SWITZ.; DA. 1977; VOL. 19; NO 3; PP. 317-323; ABS. FR.; BIBL. 19 REF.Article
INDUCTION OF THE EPSTEIN-BARR VIRUS (EBV) CYCLE IN LATENTLY INFECTED CELLS BY N-BUTYRATELUKA J; KALLIN B; KLEIN G et al.1979; VIROLOGY; USA; DA. 1979; VOL. 94; NO 1; PP. 228-231; BIBL. 24 REF.Article
PRODUCTION OF INFECTIOUS EPSTEIN-BARR VIRUS BY USING AN INTERMITTENT CULTURE COLLECTION SYSTEM.KLEIN F; ROSENSTEEL JF; HUMMER R et al.1976; APPL. ENVIRONMENT. MICROBIOL.; U.S.A.; DA. 1976; VOL. 31; NO 6; PP. 995-998; BIBL. 5 REF.Article
CHARACTERIZATION OF AN EPSTEIN-BARR VIRUS INDUCED DNA POLYMERASEOOKA T; LENOIR G; DAILLIE J et al.1979; J. VIROL.; USA; DA. 1979; VOL. 29; NO 1; PP. 1-10; BIBL. 31 REF.Article
ONCORNAVIRUS-LIKE PARTICLES RELEASED FROM ARGININE-DEPRIVED HUMAN LYMPHOBLASTOID CELL LINESKOTLER M; BALABANOVA H; WEINBERG E et al.1975; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1975; VOL. 72; NO 11; PP. 4592-4596; BIBL. 17 REF.Article
SOMATIC CELL HYBRIDS BETWEEN HUMAN LYMPHOMA CELL LINES. V: IDURD INDUCIBILITY AND P3HR-1 SUPERINFECTABILITY OF DAUDI/HELA (DAD) AND DAUDI/P3HR-1 (DIP-1) CELL LINESMOAR MH; BER R; KLEIN G et al.1978; INTERNATION. J. CANCER; CHE; DA. 1978; VOL. 22; NO 6; PP. 669-674; ABS. FRE; BIBL. 25 REF.Article
MECHANISM OF INFECTION BY EPSTEIN-BARR VIRUS. II. COMPARISON OF VIRAL DNA FROM HR-1 AND SUPERINFECTED RAJI CELLS BY RESTRICTION ENZYMES.YIH SHYONG LEE; YAJIMA Y; NONOYAMA M et al.1977; VIROLOGY; U.S.A.; DA. 1977; VOL. 81; NO 1; PP. 17-24; BIBL. 17 REF.Article
FE AND C3 RECEPTOR PATTERNS ON TWO EBV-NEGATIVE BURKITT LYMPHOMA LINES DURING ACUTE EXPOSURE TO EBV (P3HR-SUBSTRAIN)JONSSON V; KLEIN G.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 2; PP. 161-165; BIBL. 21 REF.Article
EFFECT OF SHORT-CHAIN FATTY ACIDS ON EPSTEIN-BARR VIRUS EARLY AND VIRAL CAPSID ANTIGEN INDUCTION IN P3HR-1 CELLSKAWANISHI M; ITO Y.1980; CANCER LETT.; ISSN 0304-3835; NLD; DA. 1980; VOL. 11; NO 2; PP. 129-132; BIBL. 8 REF.Article
Transformation by Epstein-Barr virus requires DNA sequences in the region of bamHI fragments Y and HSKARE, J; FARLEY, J; STROMINGER, J. L et al.Journal of virology. 1985, Vol 55, Num 2, pp 286-297, issn 0022-538XArticle
EFFECT OF INHIBITION OF DNA SYNTHESIS ON EPSTEIN-BARR VIRUS INDUCTION BY TUMOR PROMOTERSYAMAMOTO N; ZURHAUSEN H.1980; VIROLOGY; USA; DA. 1980; VOL. 101; NO 1; PP. 104-110; BIBL. 17 REF.Article
EVIDENCE FOR TYPE-C RETROVIRUS PRODUCTION BY BURKITT'S LYMPHOMADERIVED CELL LINEYANIV A; GOTLIEB STEMTSKY T; VONSOVER A et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 25; NO 2; PP. 205-211; BIBL. 2 P.Article
INDUCTION OF EPSTEIN-BARR VIRUS ANTIGENS IN HUMAN LYMPHOBLASTOID P3HR-1 CELLS WITH CULTURE FLUID OF FUSOBACTERIUM NUCLEATUMITO Y; KISHISHITA M; YANASE S et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 11; PP. 4329-4330; BIBL. 10 REF.Article
IMMUNOLOGIC IDENTIFICATION OF EPSTEIN-BARR VIRUS EARLY ANTIGEN IN A P3HR-1 CELL EXTRACT.VELTRI RW; WAIN WRIGHT WH; SPRINKLE PM et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 57; NO 2; PP. 245-253; BIBL. 34 REF.Article
PROPERTIES OF THE ONCORNAVIRUS PARTICLES ISOLATED FROM P3HR1 AND RAJI HUMAN LYMPHOBLASTOID CELL LINES.KOTLER M; BALABANOVA H; BEN MOYAL Z et al.1977; ISRAEL J. MED. SCI.; ISRAEL; DA. 1977; VOL. 13; NO 7; PP. 740-746; BIBL. 10 REF.; (INT. SYMP. MALIGNANT NEOPLAST. DIS. I; JERUSALEM; 1976)Conference Paper
Surinfection de lignées lymphoblastoïdes humaines EBV positives par un Virus sarcomatogène simien (SSV): étude biologique et moléculaire de l'expression des gènes viraux = Superinfection of EBV-positive human lymphoblastoid cell lines by a simian sarcomatogenic virus (SSV): biological and molecular study of the viral gene expressionSOUYRI CAPORALE, Michèle.1982, 131 fThesis
ABORTIVE GROWTH OF HUMAN LYMPHOCYTES CARRYING A DORMANT EPSTEIN-BARR VIRAL GENOME.AYA T; OSATO T.1978; MED. MICROBIOL. IMMUNOL.; GERM.; DA. 1978; VOL. 164; NO 4; PP. 255-266; BIBL. 2 P. 1/2Article